Mackenzie Financial’s Outset Medical OM Stock Holding History

Mackenzie Financial’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,644	Closed	-$57.3K	–	1766
2024 Q3	$57.3K	Buy	+5,644	New	+$168K	﹤0.01%	1529

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial's OM Position: Q4 2024 in Review

Mackenzie Financial sold out of Outset Medical (OM) in Q4 2024, closing a stake of 5,644 shares — an estimated $57.3K sold.

Mackenzie Financial first reported a position in OM in Q3 2024 and held it in 1 quarter. The position peaked at $57.3K in Q3 2024. 73 funds tracked by Wall St. Rank hold OM as of Q4 2024.

Mackenzie Financial reported no remaining Outset Medical position as of Q4 2024 after selling out during the quarter.
Mackenzie Financial sold 5,644 Outset Medical shares in Q4 2024, an estimated $57.3K.
Mackenzie Financial first reported a position in Outset Medical in Q3 2024 and held it in 1 quarter.
Mackenzie Financial's Outset Medical position peaked at $57.3K in Q3 2024.
73 funds tracked by Wall St. Rank held Outset Medical as of Q4 2024.

Based on Mackenzie Financial's 13F filing for Q4 2024, filed 14 Feb 2025.